通式 G(q)mAChR M(1)、M(3)、M(5) 正变构调节剂 (PAM) 先导化合物的化学 lead 优化。第一部分：第一个高选择性 M(5) PAM 的开发。
Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
机构信息
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
出版信息
Bioorg Med Chem Lett. 2010 Jan 15;20(2):558-62. doi: 10.1016/j.bmcl.2009.11.089. Epub 2009 Nov 22.
Abstract
This Letter describes a chemical lead optimization campaign directed at VU0238429, the first M(5)-preferring positive allosteric modulator (PAM), discovered through analog work around VU0119498, a pan G(q) mAChR M(1), M(3), M(5) PAM. An iterative library synthesis approach delivered the first selective M(5) PAM (no activity at M(1)-M(4) @ 30microM), and an important tool compound to study the role of M(5) in the CNS.
摘要
这封信件描述了一项针对 VU0238429 的化学先导优化活动，VU0238429 是通过对 VU0119498（一种 pan G(q) mAChR M(1)、M(3)、M(5) 正变别构调节剂（PAM））的类似物工作发现的首个 M(5) 优先 PAM。一种迭代文库合成方法提供了首个选择性 M(5) PAM（在 30μM 时对 M(1)-M(4) 无活性），这是一种重要的工具化合物，可用于研究 M(5) 在中枢神经系统中的作用。
相似文献
1
Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):558-62. doi: 10.1016/j.bmcl.2009.11.089. Epub 2009 Nov 22.
2
Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5617-22. doi: 10.1016/j.bmcl.2010.08.042. Epub 2010 Aug 12.
3
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM.
Bioorg Med Chem Lett. 2010 Mar 15;20(6):1972-5. doi: 10.1016/j.bmcl.2010.01.109. Epub 2010 Feb 1.
4
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
J Med Chem. 2009 Jun 11;52(11):3445-8. doi: 10.1021/jm900286j.
5
Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
J Biol Chem. 2014 Nov 28;289(48):33701-11. doi: 10.1074/jbc.M114.604967. Epub 2014 Oct 17.
6
Dronedarone Modulates M1 and M3 Muscarinic Receptors with Subtype Selectivity, Functional Selectivity, and Probe Dependence.
Pharmacology. 2017;99(3-4):128-138. doi: 10.1159/000453362. Epub 2016 Dec 20.
7
Simultaneous activation of mGlu and muscarinic receptors reverses MK-801-induced cognitive decline in rodents.
Neuropharmacology. 2020 Sep 1;174:107866. doi: 10.1016/j.neuropharm.2019.107866. Epub 2019 Nov 27.
8
Muscarinic acetylcholine receptor binding affinities of pethidine analogs.
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5032-5. doi: 10.1016/j.bmcl.2015.10.029. Epub 2015 Oct 19.
9
Probing the binding site of novel selective positive allosteric modulators at the M muscarinic acetylcholine receptor.
Biochem Pharmacol. 2018 Aug;154:243-254. doi: 10.1016/j.bcp.2018.05.009. Epub 2018 May 17.
10
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
Mol Pharmacol. 2016 Oct;90(4):427-36. doi: 10.1124/mol.116.104182. Epub 2016 Jul 26.
引用本文的文献
1
Cryo-EM reveals an extrahelical allosteric binding site at the M mAChR.
Nat Commun. 2025 Jul 31;16(1):7046. doi: 10.1038/s41467-025-62212-z.
2
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M.
Bioorg Med Chem Lett. 2021 Sep 1;47:128193. doi: 10.1016/j.bmcl.2021.128193. Epub 2021 Jun 9.
3
Allosteric modulation of β-cell M muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice.
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18684-18690. doi: 10.1073/pnas.1904943116. Epub 2019 Aug 26.
4
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
J Med Chem. 2019 Jan 10;62(1):88-127. doi: 10.1021/acs.jmedchem.8b00875. Epub 2018 Aug 28.
5
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M Positive Allosteric Modulators.
ACS Chem Neurosci. 2019 Mar 20;10(3):1035-1042. doi: 10.1021/acschemneuro.8b00311. Epub 2018 Aug 9.
6
Structure-Activity Relationships of Pan-Gα Coupled Muscarinic Acetylcholine Receptor Positive Allosteric Modulators.
ACS Chem Neurosci. 2018 Jul 18;9(7):1818-1828. doi: 10.1021/acschemneuro.8b00136. Epub 2018 Apr 30.
7
Discovery and Optimization of Potent and CNS Penetrant M-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold.
ACS Chem Neurosci. 2018 Jul 18;9(7):1572-1581. doi: 10.1021/acschemneuro.8b00126. Epub 2018 Apr 26.
8
Diverse Effects on M Signaling and Adverse Effect Liability within a Series of M Ago-PAMs.
ACS Chem Neurosci. 2017 Apr 19;8(4):866-883. doi: 10.1021/acschemneuro.6b00429. Epub 2017 Jan 10.
9
Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration.
Bioorg Med Chem Lett. 2016 Aug 1;26(15):3822-5. doi: 10.1016/j.bmcl.2016.04.083. Epub 2016 Apr 29.
10
Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.
Chem Rev. 2016 Jun 8;116(11):6707-41. doi: 10.1021/acs.chemrev.5b00656. Epub 2016 Feb 16.
本文引用的文献
1
Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system.
ACS Chem Neurosci. 2010;1(2):104-121. doi: 10.1021/cn900003h.
2
Parallel synthesis of N-biaryl quinolone carboxylic acids as selective M(1) positive allosteric modulators.
Bioorg Med Chem Lett. 2010 Jan 15;20(2):531-6. doi: 10.1016/j.bmcl.2009.11.100. Epub 2009 Nov 24.
3
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15950-5. doi: 10.1073/pnas.0900903106. Epub 2009 Aug 26.
4
Synthesis and structure-activity relationships of allosteric potentiators of the m(4) muscarinic acetylcholine receptor.
ChemMedChem. 2009 Oct;4(10):1600-7. doi: 10.1002/cmdc.200900231.
5
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
J Med Chem. 2009 Jun 11;52(11):3445-8. doi: 10.1021/jm900286j.
6
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.
Trends Pharmacol Sci. 2009 Mar;30(3):148-55. doi: 10.1016/j.tips.2008.12.002. Epub 2009 Feb 7.
7
Synthesis, SAR and unanticipated pharmacological profiles of analogues of the mGluR5 ago-potentiator ADX-47273.
ChemMedChem. 2009 Apr;4(4):505-11. doi: 10.1002/cmdc.200800357.
8
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.
Nat Rev Drug Discov. 2009 Jan;8(1):41-54. doi: 10.1038/nrd2760.
9
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia.
Trends Pharmacol Sci. 2009 Jan;30(1):25-31. doi: 10.1016/j.tips.2008.10.006. Epub 2008 Dec 6.
10
Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity.
Mol Pharmacol. 2009 Mar;75(3):577-88. doi: 10.1124/mol.108.052886. Epub 2008 Dec 1.
Zotero 插件